Skip to main content
Fig. 2 | Breast Cancer Research

Fig. 2

From: Validation of an AI-based solution for breast cancer risk stratification using routine digital histopathology images

Fig. 2

Prognostic stratification of patients by clinical NHG and Stratipath Breast. (a) Kaplan Meier (KM) curves for progression-free survival (PFS) among all patients stratified by clinical NHG. (b) KM curves for PFS among all patients stratified by Stratipath Breast risk groups. (c) Multivariable Cox Proportional Hazard (PH) regression estimating the association between NHG and PFS. (d) Multivariable Cox PH regression estimating the association between Stratipath Breast risk groups and PFS. (e) KM curves for PFS among ER+/HER2- patients stratified by clinical NHG. (f) KM curves for PFS among ER+/HER2- patients stratified by Stratipath Breast. (g) Multivariable Cox PH regression estimating the association between NHG and PFS in the ER+/HER2- patient subgroup. (h) Multivariable Cox PH regression estimating the association between Stratipath Breast risk groups and PFS in the ER+/HER2- subgroup. NHG = Nottingham histological grade, ER = oestrogen receptor, HER2 = human epidermal growth factor receptor 2

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us